Back to today’s briefing

Story perspectives

Revolutionary RNA Therapy Offers Hope for Vision Loss

2/23/2025

30 6

Summary

Story summary

At the Envision Summit 2025 in San Juan, Puerto Rico, Dr. Mike Farkas unveiled a groundbreaking RNA-based gene therapy designed to combat retinal degenerations. This innovative treatment promises to surpass the challenges of traditional AAV therapies and CRISPR-Cas9 editing, prioritizing both affordability and effectiveness in addressing genetic mutations that lead to vision loss.

1 of 1

Story summary

At the Envision Summit 2025 in San Juan, Puerto Rico, Dr. Mike Farkas unveiled a groundbreaking RNA-based gene therapy designed to combat retinal degenerations. This innovative treatment promises to surpass the challenges of traditional AAV therapies and CRISPR-Cas9 editing, prioritizing both affordability and effectiveness in addressing genetic mutations that lead to vision loss.